EMBOLX

Embolx is an emerging commercial-stage medical device company in Silicon Valley developing microcatheters for arterial embolization procedures. Embolx is committed to dramatically improving the treatment of a variety of conditions including cancerous tumors, benign prostatic hyperplasia and uterine fibroids. The Sniper® balloon occlusion microcatheter sets a new standard for precise embolic delivery and superior target filling by controlling pressure to direct blood flow while protecting non-target surrounding tissues. Embolx is a privately held company... APRIL 16-19, 2023: CONFERENCE Embolx is excited to be supporting and attending the European Conference on Interventional Oncology meeting in Stockholm, Sweden... May 18-21, 2023: CONFERENCE Embolx is excited to be supporting and attending the GEST meeting in New York City, NY.

Also known as: Embolx, Inc.

Primary location: Sunnyvale United States